{arrow_up} Back to top

Risk Minimisation Materials

Search by company, common medicine name, or title of Risk Minimisation Material

Blenrep

GlaxoSmithKline UK

{pdf_link}

Blenrep Cover letter for additional risk minimisation materials

{healthcare_pro_orange} For Healthcare Professionals

Cover letter when additional risk minimisation materials are distributed to HCPs


{pdf_link}

Eye examination reporting form

{healthcare_pro_orange} For Healthcare Professionals

Form to be used by eye care professional. The reported results will be sent to HCP to help make decision on belantamab mafodotin treatment.

This material has been tested with consultant ophthalmologist who has previously treated Blenrep patients.


{pdf_link}

Important Information for Eye Care Professionals: Management of eye-related side effects in patients receiving Blenrep ▼ (belantamab mafodotin)

{healthcare_pro_orange} For Healthcare Professionals

Education booklet for eye care professionals to help them understand and identify the eye-related side effects associated with belantamab mafodotin, so that AEs can be promptly identified and managed according to the SmPC


{pdf_link}

Important Information for Prescribers: Management of eye-related side effects in patients receiving Blenrep ▼ (belantamab mafodotin)

{healthcare_pro_orange} For Healthcare Professionals

Education booklet for prescribers to help them understand and identify the eye-related side effects associated with belantamab mafodotin, so that AEs can be promptly identified and managed according to the SmPC


{pdf_link}

Patient Card

{healthcare_pro_orange} For Healthcare Professionals

A patient card to record care team contact information and eye drop instructions. It can be provided to community pharmacists to assist in selecting the right eye drops.


{pdf_link}

Patient Guide: Important information on eye-related side effects that may occur with Blenrep ▼ (belantamab mafodotin)

{healthcare_pro_orange} For Healthcare Professionals

Education booklet for patients that provides an overview of eye-related side effects and how they will be monitored and managed according to SmPC.


You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?